Joel Greenblatt’s 10x Genomics TXG Stock Holding History

Joel Greenblatt’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.24M	Sell	110,660 -4,293	-4%	-$113K	0.01%	982
2026 Q1	$2.44M	Buy	114,953 +20,236	+21%	+$405K	0.01%	1051
2025 Q4	$1.54M	Buy	94,717 +75,785	+400%	+$1.14M	0.01%	1123
2025 Q3	$221K	Sell	18,932 -57,606	-75%	-$751K	﹤0.01%	1593
2025 Q2	$886K	Buy	+76,538	New	+$698K	0.01%	1174
2025 Q1	–	Sell	-18,389	Closed	-$264K	–	1664
2024 Q4	$264K	Buy	+18,389	New	+$290K	﹤0.01%	1300
2024 Q1	–	Sell	-8,686	Closed	-$486K	–	1467
2023 Q4	$486K	Buy	8,686 +1,667	+24%	+$72.5K	0.01%	999
2023 Q3	$290K	Buy	7,019 +114	+2%	+$5.93K	0.01%	1129
2023 Q2	$386K	Buy	6,905 +1,881	+37%	+$102K	0.01%	1049
2023 Q1	$280K	Buy	+5,024	New	+$235K	0.01%	1153

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Joel Greenblatt's TXG Position: Q2 2026 in Review

Joel Greenblatt reduced its 10x Genomics (TXG) stake by 3.7% in Q2 2026, selling an estimated $113K and leaving 110,660 shares worth $4.24M. The position accounts for 0.01% of the portfolio, ranked #982.

Joel Greenblatt first reported a position in TXG in Q1 2023 and has held it in 10 quarters since. 389 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Joel Greenblatt held 110,660 shares of 10x Genomics worth $4.24M as of Q2 2026.
Joel Greenblatt sold 4,293 10x Genomics shares in Q2 2026, an estimated $113K.
10x Genomics made up 0.01% of Joel Greenblatt's portfolio in Q2 2026, its #982 holding.
Joel Greenblatt first reported a position in 10x Genomics in Q1 2023 and has held it in 10 quarters since.
389 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.